Pathology as the Cornerstone of Human Tissue Banking: European Consensus Expert Group Report

Détails

ID Serval
serval:BIB_12FF66B494B6
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Pathology as the Cornerstone of Human Tissue Banking: European Consensus Expert Group Report
Périodique
Biopreservation and Biobanking
Auteur(s)
Hainaut Pierre, Caboux Elodie, Bevilacqua Generoso, Bosman Fred, Dassesse Thibaut, Hoefler Heinz, Janin Anne, Langer Rupert, Larsimont Denis, Morente Manuel, Riegman Peter, Schirmacher Peter, Stanta Giorgio, Zatloukal Kurt
ISSN
1947-5543
Statut éditorial
Publié
Date de publication
2009
Volume
7
Numéro
3
Pages
157-160
Langue
anglais
Résumé
Aside from ethical considerations, the primary requirement for usage of human tissues in basic or translational research is the thorough characterization of tissues. The second, but equally essential, requirement is that tissues be collected, processed, annotated, and preserved in optimal conditions. These requirements put the pathologist at the center of tissue banking activities and of research aimed at discovering new biomarkers. Pathologists not only provide information identifying the specimen but also make decisions on what materials should be biobanked, on the preservation conditions, and on the timeline of events that precede preservation and storage. This central position calls for increased recognition of the role of the pathologist by the biomolecular community and places new demands on the pathologist's workload and scope of scientific activities. These questions were addressed by an Expert Group Meeting of the European Biological and Biomolecular Research Infrastructure (BBMRI). While detailed recommendations are published elsewhere (Bevilacqua et al., Virchows Archivs, 2010, in press), this article outlines the strategic and technological issues identified by the Expert Group and identifies ways forward for better integration of pathology in the current thrust for development of biomarker-based "personalized medicine.
Mots-clé
Public-Health, Cancer, Biobanking, Biospecimen, Biomarkers
Web of science
Création de la notice
28/05/2010 11:04
Dernière modification de la notice
20/08/2019 12:41
Données d'usage